Simon Egli, CEO, Infors USA Inc.
Simon Egli, CEO, Infors USA Inc.
Producer of shakers, bioreactors and bioprocess control software INFORS HT has opened new offices in the US. Until now, INFORS HT has been represented in the US by ATR (Appropriate Technical Resources Inc.). From 1 January 2014, INFORS HT took over this part of the ATR business, including its infrastructure, existing customer relations and full complement of staff.
In order to guarantee a seamless continuity of service to customers, all sales and service offices as well as production teams remain unchanged, as does any current contact personnel. By increasing its presence in the US, INFORS HT will not only expand its customer base but give its customers direct day-to-day contact with INFORS HT representatives and no longer via a third party.
Marcel Brauchli, CEO of INFORS HT, pointed out: “We’re proud of our new branches and look forward to having direct contact with our customers in the US. We’re convinced that, in this way, we can improve customer relations and build more successful long term partnerships.”
This new direct contact will also bring about an added value to customers. They will have access to a committed team with a wealth of experience, technical know-how and innovative thinking.
The new CEO of Infors USA Inc., Simon Egli, holds a master degree in biotechnology engineering from the University of Waedenswil, Switzerland. Before joining INFORS HT at the headquarters in Switzerland, he worked in various bioprocess production and validation positions at management level. He has been with INFORS HT for three years.
Infors USA Inc., +1 301 362 3710, infors.usa@infors-ht.com, www.infors-ht.us.